theophylline has been researched along with Bilateral Headache in 23 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients kept records of peak flow meter (PFM) measurements, asthma attack rate and beta-2-agonist use (albuterol)." | 9.10 | Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial. ( Chervinsky, P; Goldstein, MF, 2002) |
| "To determine whether controlled-release theophylline inhibits the development of airway obstruction and/or airway hyperresponsiveness early in the morning, we examined 18 subjects reporting recurrent nocturnal asthma." | 9.08 | Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects. ( Boschetto, P; Crescioli, S; Dal Carobbo, A; Fabbri, LM; Hurst, TS; Maestrelli, P; Parise, G; Santagada, T; Steinijans, VW, 1996) |
| "Although theophylline is recommended by current guidelines for the management of asthma in patients with persistent symptoms, theophylline has a narrow therapeutic index, requiring individual dose titration and regular monitoring of serum theophylline concentrations to avoid adverse effects." | 9.08 | Salmeterol versus theophylline in the treatment of asthma. ( Cox, FM; Emmett, A; Pollard, SJ; Spector, SL; Yancey, SW, 1997) |
| "Fifteen asthmatic outpatients were randomly treated during two periods of 14 days each with sustained-release preparations of either enprofylline (3-propyl-xanthine) or theophylline (Theo-Dur) in a double-blind crossover study." | 9.06 | Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison. ( Eriksson, G; Laursen, LC; Weeke, B, 1986) |
| "Twenty-five asthmatic outpatients were treated for 3 one-week periods with either enprofylline slowly eroding 300 mg tablets t." | 9.05 | Continuous treatment of asthmatic patients with enprofylline and theophylline. ( Johannesson, N; Laursen, LC; Weeke, B, 1984) |
| "Bronchodilation and side effects of 28 days treatment with either a full therapeutic dose of theophylline slow-release preparation 500 mg twice daily (400-600 mg), a slow-release terbutaline preparation 10 mg twice daily or combinations of the 2 drugs in full or half doses were evaluated in 31 asthmatic outpatients in a double-blind, randomized crossover design." | 9.05 | Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. ( Gnosspelius, Y; Gymose, E; Laursen, LC; Taudorf, E; Weeke, B, 1985) |
| " This study was performed to compare the efficacy of inhaled corticosteroids (ICS) combined with slow-release theophylline (SRT) with that of double-dose ICS in asthma control, anti-inflammatory activity and safety." | 6.71 | Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma. ( Li, SP; Liao, XQ; Lin, KX; Qian, GS; Song, YX; Wang, CZ; Wang, Y; Zhao, ZQ; Zhuo, WL, 2005) |
| " Patients kept records of peak flow meter (PFM) measurements, asthma attack rate and beta-2-agonist use (albuterol)." | 5.10 | Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial. ( Chervinsky, P; Goldstein, MF, 2002) |
| "To determine whether controlled-release theophylline inhibits the development of airway obstruction and/or airway hyperresponsiveness early in the morning, we examined 18 subjects reporting recurrent nocturnal asthma." | 5.08 | Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects. ( Boschetto, P; Crescioli, S; Dal Carobbo, A; Fabbri, LM; Hurst, TS; Maestrelli, P; Parise, G; Santagada, T; Steinijans, VW, 1996) |
| "Although theophylline is recommended by current guidelines for the management of asthma in patients with persistent symptoms, theophylline has a narrow therapeutic index, requiring individual dose titration and regular monitoring of serum theophylline concentrations to avoid adverse effects." | 5.08 | Salmeterol versus theophylline in the treatment of asthma. ( Cox, FM; Emmett, A; Pollard, SJ; Spector, SL; Yancey, SW, 1997) |
| "Fifteen asthmatic outpatients were randomly treated during two periods of 14 days each with sustained-release preparations of either enprofylline (3-propyl-xanthine) or theophylline (Theo-Dur) in a double-blind crossover study." | 5.06 | Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison. ( Eriksson, G; Laursen, LC; Weeke, B, 1986) |
| "Twenty-five asthmatic outpatients were treated for 3 one-week periods with either enprofylline slowly eroding 300 mg tablets t." | 5.05 | Continuous treatment of asthmatic patients with enprofylline and theophylline. ( Johannesson, N; Laursen, LC; Weeke, B, 1984) |
| "Bronchodilation and side effects of 28 days treatment with either a full therapeutic dose of theophylline slow-release preparation 500 mg twice daily (400-600 mg), a slow-release terbutaline preparation 10 mg twice daily or combinations of the 2 drugs in full or half doses were evaluated in 31 asthmatic outpatients in a double-blind, randomized crossover design." | 5.05 | Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. ( Gnosspelius, Y; Gymose, E; Laursen, LC; Taudorf, E; Weeke, B, 1985) |
| "During the 1980 influenza B outbreak in King County, Washington, 11 children whose asthma had previously been controlled with a stable theophylline dose, developed theophylline toxicity on this same dose." | 3.66 | Altered theophylline clearance during an influenza B outbreak. ( Bierman, CW; Furukawa, CT; Koup, JR; Kraemer, MJ; Pierson, WE; Shapiro, GG, 1982) |
| " This study was performed to compare the efficacy of inhaled corticosteroids (ICS) combined with slow-release theophylline (SRT) with that of double-dose ICS in asthma control, anti-inflammatory activity and safety." | 2.71 | Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma. ( Li, SP; Liao, XQ; Lin, KX; Qian, GS; Song, YX; Wang, CZ; Wang, Y; Zhao, ZQ; Zhuo, WL, 2005) |
| " No significant changes in other theophylline pharmacokinetic parameters were evident." | 2.69 | Lack of effect of dirithromycin on theophylline pharmacokinetics in healthy volunteers. ( Amsden, GW; McConnell, SA; Nafziger, AN, 1999) |
| " Pharmacokinetic characteristics of 2 batches at the lower (T1) and the upper (T2) in vitro dissolution specification range of this new formulation and a pellet formulation (R) as a comparator were evaluated in an open, randomized, 3-way, multiple-dose, crossover study design with an asymmetric dosage regimen of 400 mg and 200 mg theophylline." | 2.68 | Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet. ( Fuchs, WS; Gay, S; Laicher, A; Müller, M; Pabst, G; Von Nieciecki, A; Weiss, G, 1996) |
| " We found no evidence of a pharmacokinetic interaction between theophylline and erythromycin at steady state." | 2.65 | The effect of erythromycin on theophylline pharmacokinetics at steady state. ( Bauman, JL; Hasegawa, GR; Leeds, NH; Maddux, MS; Organek, HW, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (69.57) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MOYER, JH | 1 |
| TASHNEK, AB | 1 |
| MILLER, SI | 1 |
| SNYDER, H | 1 |
| BOWMAN, RO | 1 |
| MOELLHOFF, G | 1 |
| Wang, Y | 1 |
| Wang, CZ | 1 |
| Lin, KX | 1 |
| Qian, GS | 1 |
| Zhuo, WL | 1 |
| Li, SP | 1 |
| Zhao, ZQ | 1 |
| Liao, XQ | 1 |
| Song, YX | 1 |
| Busse, WW | 1 |
| Smith, A | 1 |
| Laursen, LC | 3 |
| Johannesson, N | 1 |
| Weeke, B | 3 |
| Brown, DL | 1 |
| Maddux, MS | 2 |
| Organek, HW | 2 |
| Bauman, JL | 2 |
| Leeds, NH | 1 |
| Hasegawa, GR | 1 |
| Kraemer, MJ | 1 |
| Furukawa, CT | 1 |
| Koup, JR | 1 |
| Shapiro, GG | 1 |
| Pierson, WE | 1 |
| Bierman, CW | 1 |
| Schneck, DW | 1 |
| Crescioli, S | 1 |
| Dal Carobbo, A | 1 |
| Maestrelli, P | 1 |
| Boschetto, P | 1 |
| Santagada, T | 1 |
| Steinijans, VW | 1 |
| Hurst, TS | 1 |
| Parise, G | 1 |
| Fabbri, LM | 1 |
| Fuchs, WS | 1 |
| Weiss, G | 1 |
| Von Nieciecki, A | 1 |
| Laicher, A | 1 |
| Gay, S | 1 |
| Pabst, G | 1 |
| Müller, M | 1 |
| Pollard, SJ | 1 |
| Spector, SL | 1 |
| Yancey, SW | 1 |
| Cox, FM | 1 |
| Emmett, A | 1 |
| McConnell, SA | 1 |
| Nafziger, AN | 1 |
| Amsden, GW | 1 |
| Goldstein, MF | 1 |
| Chervinsky, P | 1 |
| Wessely, P | 1 |
| Arnold, JD | 1 |
| Courtenay-Evans, RJ | 1 |
| Whitfield, R | 1 |
| O'Reilly, JF | 1 |
| Petrie, GR | 1 |
| Higgins, AJ | 1 |
| Swift, CG | 1 |
| Taudorf, E | 1 |
| Gnosspelius, Y | 1 |
| Gymose, E | 1 |
| Eriksson, G | 1 |
| Engel, K | 2 |
| Pramer, I | 2 |
| Fischer, M | 1 |
| Kopp, H | 1 |
| Hochrein, M | 1 |
| Schleicher, I | 1 |
| Pichler, E | 1 |
| Strauss, A | 1 |
| Wunderlich, E | 1 |
15 trials available for theophylline and Bilateral Headache
| Article | Year |
|---|---|
Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.
Topics: Administration, Inhalation; Adult; Asthma; Beclomethasone; Bronchodilator Agents; Dose-Response Rela | 2005 |
Combination low-dose metaproterenol-theophylline therapy in asthma.
Topics: Administration, Oral; Adolescent; Adult; Asthma; Clinical Trials as Topic; Drug Combinations; Drug T | 1983 |
Continuous treatment of asthmatic patients with enprofylline and theophylline.
Topics: Adult; Aged; Asthma; Bronchodilator Agents; Clinical Trials as Topic; Double-Blind Method; Female; H | 1984 |
The effect of erythromycin on theophylline pharmacokinetics at steady state.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Erythromycin; Female; Headache; Humans; Kinet | 1982 |
Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects.
Topics: Administration, Inhalation; Administration, Oral; Adult; Airway Obstruction; Asthma; Circadian Rhyth | 1996 |
Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Topics: Aged; Area Under Curve; Bronchodilator Agents; Capsules; Delayed-Action Preparations; Female; Headac | 1996 |
Salmeterol versus theophylline in the treatment of asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Al | 1997 |
Lack of effect of dirithromycin on theophylline pharmacokinetics in healthy volunteers.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Drug Interactions; Drug Therapy, Combination; Dyspep | 1999 |
Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Asthma; Dose-Response Relationship, Drug | 2002 |
[Therapy of the post-commotion syndrome].
Topics: Benzamides; Brain Concussion; Drug Combinations; Drug Evaluation; Headache; Hexobendine; Humans; Nau | 1976 |
Comparative assessment of enprofylline and theophylline for chronic obstructive airways disease in the elderly.
Topics: Aged; Bronchodilator Agents; Double-Blind Method; Female; Headache; Humans; Lung Diseases, Obstructi | 1990 |
Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined.
Topics: Administration, Oral; Adolescent; Adult; Aged; Akathisia, Drug-Induced; Arrhythmias, Cardiac; Asthma | 1985 |
Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison.
Topics: Adult; Asthma; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Headache; | 1986 |
[Experiences with a hexobendine combination preparation].
Topics: Aged; Benzamides; Benzoates; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Combinations; | 1973 |
[Treatment of chronic bronchitic syndrome].
Topics: Adult; Aged; Air Pollution; Anxiety; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Com | 1973 |
8 other studies available for theophylline and Bilateral Headache
| Article | Year |
|---|---|
The effect of theophylline with ethylenediamine (aminophylline) and caffeine on cerebral hemodynamics and cerebrospinal fluid pressure in patients with hypertensive headaches.
Topics: Aminophylline; Caffeine; Cerebrospinal Fluid Pressure; Ethylenediamines; Headache; Hemodynamics; Hum | 1952 |
[INCIDENTS IN REID'S INTRACISTERNAL THERAPY WITH PROCAINE-CAFFEINE MIXTURES].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Caffeine; Encephalomyelitis; Epilepsy; Headache; | 1963 |
Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
Topics: Administration, Oral; Adult; Asthma; Delayed-Action Preparations; Female; Headache; Humans; Male; Th | 1983 |
Altered theophylline clearance during an influenza B outbreak.
Topics: Asthma; Child; Disease Outbreaks; Headache; Humans; Influenza, Human; Male; Metabolic Clearance Rate | 1982 |
Therapeutic rounds at the Milton S. Hershey Medical Center.
Topics: Adolescent; Asthma; Cimetidine; Female; Guanidines; Headache; Humans; Nausea; Theophylline | 1981 |
[Possibility of improvement of cerebral function under the effect of prolonged combined infusions-injections oral therapy in geriatrics].
Topics: Administration, Oral; Aged; Attention; Benzamides; Benzoates; Blood Pressure; Catechols; Central Ner | 1971 |
[Cerebral disorders and their treatment].
Topics: Aminopyrine; Drug Combinations; Fatigue; Glycyrrhiza; Headache; Humans; Mistletoe; Plants, Medicinal | 1972 |
[Ophthalmodynamographic studies in spontaneous and pharmacologically induced vascular headache].
Topics: Adult; Age Factors; Benzoates; Blood Pressure; Blood Volume; Brachial Artery; Cerebrovascular Circul | 1968 |